𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum adiponectin levels in cholesterol and pigment cholelithiasis

✍ Scribed by S.-N. Wang; Y.-T. Yeh; M.-L. Yu; C.-L. Wang; K.-T. Lee


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
142 KB
Volume
93
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Serum levels of adiponectin in patients
✍ Stefan Landgraeber; Alexander Wegner; Ali Canbay; Marius von Knoch πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 324 KB

## Abstract The purpose of this study was to elucidate if the adiponectin level correlates with the survival of joint replacements. Current data indicates that adiponectin regulates lipid and glucose metabolism and acts anti‐inflammatory and anti‐apoptotic. We compared the value of adiponectin in s

Serum antioxidant and cholesterol levels
✍ Clifford Abiaka; Farida Al-Awadi; Hilal Al-Sayer; Sima Gulshan; Abdulla Behbehan πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 48 KB

## Abstract Serum antioxidant (urate, α‐tocopherol) activity and cholesterol concentration in 142 patients of Indian and Arab (Kuwaitis and other Arabs) origin with different types of cancer (breast, colon, stomach, thyroid, oral, rectal, pancreatic, and renal) were compared to 100 age‐ and sex‐mat

Total serum cholesterol levels and Alzhe
✍ V. P. Prasher; E. Airuehia; A. Patel; M. S. Haque πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 1 views

## Abstract ## Background The risk for dementia in Alzheimer's disease (DAD) in adults with Down syndrome (DS) is higher than in the general adult population. Hypercholesterolaemia has been reported as a risk factor for DAD in the general population. This study investigated the role of serum chole

Serum level of adiponectin and the risk
✍ Toru Arano; Hayato Nakagawa; Ryosuke Tateishi; Hitoshi Ikeda; Koji Uchino; Kenic πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 321 KB πŸ‘ 1 views

## Abstract Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC). Dysregulation of adipokines, particularly the decreased secretion of adiponectin, appears to play a key role. To investigate the assoc